Plethora Solutions Holdings Plc Regulatory News (PLE)

21 Apr 2008 11:13

Plethora Solutions Holdings PLC21 April 2008 Immediate Release: 21st April 2008 Plethora Solutions Holdings plc Notice of Preliminary Results Plethora Solutions Holdings plc ('Plethora', AIM:PLE), the specialist developerof products for the treatment and management of urological disorders, willannounce its preliminary results for the year ended 31 December 2007 on Tuesday29 April 2008. An analyst meeting will be held at 9.30 am at the offices of Collins Stewart,9th Floor, 88 Wood Street, London EC2V 7QR. -Ends- For further information please contact: Plethora Solutions Holdings plc 020-3077-5400 Steven Powell Hansard Group 020-7245-1100 Adam Reynolds John Bick About Plethora Plethora is focused on the development and marketing of products for thetreatment of urological disorders. The Company has products in clinicaldevelopment for the treatment of overactive bladder, stress urinaryincontinence, interstitial cystitis, gynaecological pain, erectile dysfunctionand premature ejaculation. Plethora has a US subsidiary, Timm MedicalTechnologies Inc, which markets products for the treatment of erectiledysfunction (ED) to urology clinics through a national US specialty sales team.The Company is headquartered in the UK and is listed on the London StockExchange (AIM:LSE). Further information is available atwww.plethorasolutions.co.uk This information is provided by RNS The company news service from the London Stock Exchange